Michael I Schneider

US Patent:

6513882, Feb 4, 2003

Filed:

Aug 7, 2000

Appl. No.:

09/633213

Inventors:

Michael John Schneider - Bloomfield Township MI
Dale Scott Crombez - Livonia MI

Assignee:

Ford Global Technologies, Inc. - Dearborn MI

International Classification:

B60T 852

US Classification:

303112

Abstract:

A brake assembly for use within an electric vehicle and which allows the vehicle to be selectively decelerated in substantially the same manner as is an internal combustion engine type vehicle upon the release of an accelerator pedal member or the depression of a brake member.

US Patent:

7024290, Apr 4, 2006

Filed:

Jul 30, 2004

Appl. No.:

10/903326

Inventors:

Yifan Zhao - Belleville MI, US
Michael Schneider - Bloomfield Township MI, US
Dale Crombez - Livonia MI, US

Assignee:

Ford Global Technologies, LLC - Dearborn MI

International Classification:

G06F 17/00
B60K 6/04

US Classification:

701 22, 701 38, 701 71, 701 91, 180 656

Abstract:

A system and method for actively damping driveline oscillations in a motor vehicle having a traction motor to drive a vehicle's drive wheels and an antilock brake system (ABS). A traction motor controller controls a torque output signal of the motor to effectively to dampen driveline oscillations during an ABS operation. A proportional, a proportional derivative, or a derivative controller may be used to generate the torque output signal based on at least one of motor speed, an average of the drive wheel speeds, a difference in the two speeds, a motor angular acceleration, an average wheel angular acceleration, and a difference in the angular accelerations. Motor speed signals and average drive wheel speed signals may be filtered to eliminate high frequency components of each speed signal. Additionally, amplitude of the torque output signal may be limited within a positive upper and a negative lower active motor damping limit.

US Patent:

7093912, Aug 22, 2006

Filed:

Sep 1, 2004

Appl. No.:

10/932132

Inventors:

Todd Allen Brown - Dearborn MI, US
Michael John Schneider - Bloomfield Township MI, US

Assignee:

Ford Motor Company - Dearborn MI

International Classification:

B60T 8/60
B60T 8/64

US Classification:

303146, 303152

Abstract:

The present invention is a method and system to control regenerative braking during the operation of a yaw stability control system. The method and system use feedback control algorithms to monitor and dynamically modify regenerative and non-regenerative braking. The controller can use a simple proportional-integral-derivative feedback controller. A vehicle yaw stability control system can determine if a vehicle is experiencing an oversteer or understeer condition. The controller compares actual brake balance to a desired brake balance. The controller determines if the front axle wheels are overbraked relative to the rear axle wheels or if the rear axle wheels are overbraked relative to the front axle wheels as compared to the desired brake balance. The controller can adjust regenerative braking and non-regenerative braking levels according to the determinations.

US Patent:

7441845, Oct 28, 2008

Filed:

Sep 13, 2004

Appl. No.:

10/939575

Inventors:

Dale S. Crombez - Livonia MI, US
Michael J. Schneider - Bloomfield Township MI, US

Assignee:

Ford Global Technologies, LLC - Dearborn MI

International Classification:

B60T 8/64

US Classification:

303152

Abstract:

A system and method for maximizing the post-ABS regenerative braking capability of an automotive vehicle having regenerative braking available for more than one axle determines the availability of surplus regenerative braking capacity on a first axle and then uses the surplus, if any, to satisfy the brake demand for another axle having insufficient regenerative braking capacity. This system restores regenerative braking without causing the regenerative braking to trigger a subsequent ABS event.

US Patent:

20010008026, Jul 12, 2001

Filed:

Jun 25, 1998

Appl. No.:

09/104654

Inventors:

MICHAEL D. SCHNEIDER - HOUSTON TX, US
PAUL OVERBEEK - HOUSTON TX, US
PETER FRENKEL - HOUSTON TX, US

International Classification:

A01K067/027

US Classification:

800/008000, 800/009000, 800/014000, 800/018000, 800/003000, 800/021000, 800/022000, 800/025000, 435/455000, 435/462000, 435/463000, 435/465000, 435/325000

Abstract:

The present invention relates to methods and compositions for tissue-restricted gene recombination. In particular, the present invention provides methods and compositions for tissue-restricted gene recombination in post-mitotic cells. The present invention further provides methods for gene recombination in post-mitotic cells comprising the delivery of a Cre recombinase to the target tissue to facilitate recombination in a desired target nucleic acid.

US Patent:

20040082613, Apr 29, 2004

Filed:

Jun 27, 2003

Appl. No.:

10/609073

Inventors:

Michael Schneider - Houston TX, US
Motoaki Sano - Houston TX, US

International Classification:

A61K031/452
A61K031/401

US Classification:

514/320000, 514/423000

Abstract:

The present invention relates generally to the field of cardiology. More particularly, the present invention relates to methods of using inhibitors of cyclin dependent kinase 9 (Cdk9) to treat cardiovascular disease by blunting cardiac hypertrophy.

US Patent:

20040106647, Jun 3, 2004

Filed:

Sep 19, 2003

Appl. No.:

10/665336

Inventors:

Michael Schneider - Houston TX, US
Motoaki Sano - Houston TX, US

International Classification:

A61K031/452

US Classification:

514/320000

Abstract:

The present invention relates generally to the field of cardiology. More particularly, the present invention relates to methods of using inhibitors of cyclin dependent kinase 9 (Cdk9) to treat cardiovascular disease by blunting cardiac hypertrophy.

US Patent:

20040126879, Jul 1, 2004

Filed:

Aug 29, 2003

Appl. No.:

10/651548

Inventors:

Michael Schneider - Houston TX, US
Hidemasa Oh - Houston TX, US
Mark Entman - Houston TX, US

Assignee:

Baylor College of Medicine - Houston TX

International Classification:

C12N005/08

US Classification:

435/372000, 435/366000, 424/093700

Abstract:

The present invention is drawn to compositions and methods of using the same to cardiovascular disease. The compositions of the present invention are cardiac stem cells that are c-kit/CD31/CD38 and express telomerase reverse transcriptase.